Literature DB >> 18292133

Treatment delays in ST elevation myocardial infarction.

Christian Juhl Terkelsen, Jens Flensted Lassen.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18292133      PMCID： PMC2249632          DOI： 10.1136/bmj.39475.482419.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

Review 2.  Myocardial infarction centres: the way forward.

Authors:  H R Andersen; C J Terkelsen; L Thuesen; L R Krusell; S D Kristensen; H E Bøtker; J F Lassen; T T Nielsen
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 3.  Time to treatment in primary percutaneous coronary intervention.

Authors:  Brahmajee K Nallamothu; Elizabeth H Bradley; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

Review 4.  Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.

Authors:  William E Boden; Kim Eagle; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2007-08-21       Impact factor: 24.094

5.  Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jens Flensted Lassen; Bjarne Linde Nørgaard; Jens Christian Gerdes; Steen Hvitfeldt Poulsen; Kristoffer Bendix; Jens Peter Ankersen; Liv Bjørn-Hansen Gøtzsche; Frode Kirketerp Rømer; Torsten Toftegaard Nielsen; Henning Rud Andersen
Journal:  Eur Heart J       Date:  2005-01-31       Impact factor: 29.983

6.  Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction.

Authors:  David J Magid; Yongfei Wang; Jeph Herrin; Robert L McNamara; Elizabeth H Bradley; Jeptha P Curtis; Charles V Pollack; William J French; Martha E Blaney; Harlan M Krumholz
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

8.  Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.

Authors:  Eric Boersma
Journal:  Eur Heart J       Date:  2006-03-02       Impact factor: 29.983

9.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
  9 in total
  1 in total

1.  Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI--the STOP WATCH study: a multistage action research project.

Authors:  Tim Tödt; Ingela Thylén; Joakim Alfredsson; Eva Swahn; Magnus Janzon
Journal:  BMJ Open       Date:  2013-09-03       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.